What is Next in Cancer Care? Ten Years' Predictions from Now
DOI:
https://doi.org/10.32635/2176-9745.RBC.2024v70n1.4628Keywords:
Neoplasms/epidemiology, Medical Oncology, Antineoplastic ProtocolsAbstract
The treatment of cancer patients has undergone numerous advances, especially in the last two decades when changes in surgical techniques, the modernization of radiotherapy, and a better understanding of carcinogenesis (leading to the development of targeted therapy and immunotherapies), in addition to supportive treatment and integration of the multidisciplinary team brought substantial gains in oncological outcomes and better quality of life. In this editorial, expected advances in cancer care for the next decade are listed.
Downloads
References
Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med. 1948;238(23):787-93.
Karnofsky DA, Burchenal JH. Experimental observations on the effects of the nitrogen mustards on neoplastic tissues. Cancer Res. 1947;7(1):50.
DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643-53.
Dogan NU, Dogan S, Favero G, et al. The basics of sentinel lymph node biopsy: anatomical and pathophysiological considerations and clinical aspects. J Oncol. 2019;2019:1-10.
Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol. 2015;12(2):115-24.
Garibaldi C, Jereczek-Fossa BA, Marvaso G, et al. Recent advances in radiation oncology. ecancermedicalscience [Internet]. 2017 [acesso 2024 mar 5];11:785. Disponível em: http://www.ecancer.org/journal/11/full/785-recent-advances-inradiation-oncology.php
Sarhadi VK, Armengol G. Molecular biomarkers in cancer. Biomolecules. 2022;12(8):1021.
Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2(2):115-52.
Ajmera Y, Singhal S, Dwivedi S, et al. The changing perspective of clinical trial designs. Perspect Clin Res. 2021;12(2):66.
Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol. 2020;38(24):2782-97.
Link H. Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF). Support Care Cancer. 2022;30(9):7067-77.
Bohlius J, Bohlke K, Castelli R, et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: asco/ash clinical practice guideline update. J Clin Oncol. 2019;37(15):1336-51.
Paice JA, Bohlke K, Barton D, et al. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. J Clin Oncol. 2023;41(4):914-30.
Parikh RB, Kirch RA, Smith TJ, et al. Early specialty palliative care - translating data in oncology into practice. N Engl J Med. 2013;369(24):2347-51.
Min HY, Lee HY. Molecular targeted therapy for anticancer treatment. Exp Mol Med. 2022;54(10):1670-94.
Shiravand Y, Khodadadi F, Kashani SMA, et al. Immune checkpoint inhibitors in cancer therapy. Curr Oncol. 2022;29(5):3044-60.
Wang L, Liu G, Zheng L, et al. A new era of gene and cell therapy for cancer: a narrative review. Ann Transl Med. 2023;11(9):321.
Lin MJ, Svensson-Arvelund J, Lubitz GS, et al. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3(8):911-26.
Dumontet C, Reichert JM, Senter PD, et al. Antibody-drug conjugates come of age in oncology. Nat Rev Drug Discov. 2023;22(8):641-61.
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
